Showing results (1-10 of 616) with videos related to
Sort By:
Pageof 62
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 1, 1997
Progress towards optimal trial end-points in rheumatoid arthritisM Boers, P Tugwell, P M BrooksThe Journal of Rheumatology|March 1, 1993
The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trialsM Boers, P TugwellThe Journal of Rheumatology|March 1, 1993
OMERACT conference questionnaire results. OMERACT CommitteeM Boers, P TugwellClinical and Experimental Rheumatology|November 7, 2006
Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activityG Wells, M Boers, P Tugwell, et al.British Journal of Rheumatology|July 17, 1998
Combination therapy in rheumatoid arthritis: updated systematic reviewA C Verhoeven, M Boers, P TugwellThe Journal of Rheumatology|March 1, 1993
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT CommitteeC H Goldsmith, M Boers, C Bombardier, et al.British Journal of Rheumatology|April 1, 1988
An evaluation of the role of laboratory investigations in establishing a diagnosis of central nervous system lupusL Schrieber, M McCredie, P Tugwell, et al.The Journal of Rheumatology. Supplement|October 1, 1994
Endpoints in rheumatoid arthritisP Tugwell, M Boers, P Baker, et al.Clinical and Experimental Rheumatology|November 9, 2005
OMERACT: an international initiative to improve outcome measurement in rheumatologyM Boers, P Brooks, L S Simon, et al.Bailliere'S Clinical Rheumatology|May 1, 1995
Assessing the activity of rheumatoid arthritisM Boers, P L van Riel, D T Felson, et al.Pageof 62